Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Biotech
Health
STAT+
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Politics
STAT+

Teva quits brand lobby PhRMA, in line to lead generic lobby AAM

  • John Wilkerson

By John Wilkerson Feb. 2, 2023

Reprints
Teva building
Adobe

WASHINGTON  — Teva Pharmaceuticals has quit the Pharmaceutical Research and Manufacturers of America, STAT has learned.  

“Teva has decided not to renew its membership with PhRMA in 2023,” PhRMA spokesperson Brian Newell confirmed.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

John Wilkerson

John Wilkerson

Washington Correspondent

John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care.

Tags

Create a display name to comment

This name will appear with your comment

Shortage of monkeys for early-stage research jeopardizes timelines for…
Shortage of monkeys for early-stage research jeopardizes timelines for developing some drugs
Our child received a devastating diagnosis before she was…
Our child received a devastating diagnosis before she was born. We decided to protect her
‘Microdosing’ is touted by ’shroomers and Reddit users. Science…
‘Microdosing’ is touted by ’shroomers and Reddit users. Science is starting to test their claims —…
Former J&J exec, an in-demand free agent, takes the…
Former J&J exec, an in-demand free agent, takes the helm at privately held FogPharma
Is there $21 billion left for Covid response, or…
Is there $21 billion left for Covid response, or $5 billion? The White House is using…
Dutch health minister won’t cover a Gilead cancer drug…
Dutch health minister won’t cover a Gilead cancer drug due to the cost

Recommended Stories